FORM vs LevelsRx

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

FORM

Provider comparison

Shoppers who want published month-to-month prices on compounded semaglutide or tirzepatide, with tablet and brand-name options on the same account.

Semaglutide / month: $159/moMonth-to-month after a $99 first month, compounded
Tirzepatide / month: $219/moMonth-to-month after a $169 first month, compounded

Index 81/100 · Grade B−Checked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check FORM pricing Read review

LevelsRx

Provider comparison

Shoppers who want a low published starting price on compounded semaglutide or tirzepatide, with an oral option and no membership fee.

Semaglutide / month: $88/moStarting price, shown as a sale from a struck-through $249; oral liquid from $108, compounded
Tirzepatide / month: $188/moStarting price, shown as a sale from a struck-through $349, compounded

Index 81/100 · Grade B−Checked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check LevelsRx pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 81/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

FORM: 48 states + Washington, D.C. — excludes Alaska and Mississippi
LevelsRx: All 50 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

FORM

LevelsRx

Semaglutide / month: FORM: $159/moMonth-to-month after a $99 first month, compounded; LevelsRx: $88/moStarting price, shown as a sale from a struck-through $249; oral liquid from $108, compounded

Tirzepatide / month: FORM: $219/moMonth-to-month after a $169 first month, compounded; LevelsRx: $188/moStarting price, shown as a sale from a struck-through $349, compounded

Semaglutide / year (modeled): FORM: $1,908; LevelsRx: $1,056

Tirzepatide / year (modeled): FORM: $2,628; LevelsRx: $2,256

State availability: FORM: 48 states + Washington, D.C. — excludes Alaska and Mississippi; LevelsRx: All 50 states

Oral / sublingual option listed: FORM: Yes; LevelsRx: Yes

Brand-name access listed: FORM: Yes; LevelsRx: Not confirmed

Provider facts checked: FORM: October 2026; LevelsRx: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

FORM

Shoppers who want published month-to-month prices on compounded semaglutide or tirzepatide, with tablet and brand-name options on the same account.

Reasons to consider it

Publishes its prices before you start: compounded semaglutide $159 a month and tirzepatide $219 after a lower first month ($99 and $169)
Wide menu on one account: injections, dissolving tablets, B12 and glycine blends, and Wegovy pill or Zepbound memberships
Names its board-certified clinicians, including a family-medicine physician and a DO

What to weigh up

The '$95/mo' Wegovy pill and Zepbound memberships cover care only; the drug is bought separately and FORM doesn't print what it costs
Each plan's first-month price is lower than what you pay from month two on
Doesn't name the pharmacy that fills your prescription

Compounded drugs are not FDA-approved. Understand the medication options.

Check FORM pricing Read the full FORM review

LevelsRx

Shoppers who want a low published starting price on compounded semaglutide or tirzepatide, with an oral option and no membership fee.

Reasons to consider it

Low published starting prices: compounded semaglutide from $88 a month, tirzepatide from $188 and oral semaglutide liquid from $108
No membership fee, and the price includes the consultation, medication, supplies and delivery
Names its two partner compounding pharmacies, in Utah and New York

What to weigh up

Every price is shown as a sale against a much higher crossed-out figure, under a countdown that never seems to end
The figures are 'starting at' prices, and LevelsRx doesn't publish what higher doses cost
Its refund policy says fees aren't refunded if you cancel mid-cycle

Compounded drugs are not FDA-approved. Understand the medication options.

Check LevelsRx pricing Read the full LevelsRx review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

FORMLevelsRx

Normalized Cost/Month: FORM:
81/100; LevelsRx:
86/100

Price Transparency: FORM:
86/100; LevelsRx:
84/100

Nationwide Access: FORM:
86/100; LevelsRx:
86/100

Formulation Options: FORM:
90/100; LevelsRx:
77/100

Clinical Oversight: FORM:
68/100; LevelsRx:
76/100

Contract Flexibility: FORM:
67/100; LevelsRx:
67/100

Before you sign up

Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to FORM Alternatives to LevelsRx

More provider matchups

CoreAge Rx vs FORM CoreAge Rx vs LevelsRx

Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.